O. B. Parrish

Abiant, Inc. provides advanced imaging technology services. The firm designs, conducts, and analyzes neuroimaging studies for pharmaceutical partners to assess drug effects upon the brain. Its image data, which can be collected using small numbers of subjects, provides insight to a drug's brain penetration, target interaction, effects upon brain function, and impact upon disease pathology. The company was founded in 2005 and is headquartered in Grayslake, IL.

ADM Diagnostics, Inc. provides cutting edge analysis of brain images to enable disease diagnosis, outcome prediction, and detection of treatment effect. The company is headquartered in Northbrook, IL.

Zila, Inc., headquartered in Scottsdale, Arizona and founded in 1988, is a diagnostic company that offers prevention, detection and treatment of oral cancer and periodontal disease. Zila manufactures and markets ViziLite Plus with TBlue (“ViziLite Plus”), the company’s product for the detection of oral abnormalities that could lead to cancer. ViziLite Plus is a medical device for use in a popilation risking for oral cancer. Zila designs, manufactures and markets products sold directly to dental professionals for periodontal disease, including the Rotadent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler and oral pharmaceutical products for both in-office and home-care use

MIICRO, Inc. develops pharmaceuticals for the central nervous system. It uses neuroimaging technology to research and develop pharmaceuticals for the central nervous system. The company's customers include GlaxoSmithKline, Pfizer, and Eli Lilly. It was founded in 1994 and is located in Chicago, IL

G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985.